Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26F1FRK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,080
Award facts
- Contract value 100% obligated
- $24,079.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,079.93 to AmerisourceBergen Drug Corp for COSENTYX (secukinumab) 300mg dose, 2 pens per milliliter. This is a firm fixed-price, non-set-aside contract with a completion date of November 18, 2025, issued on November 17, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of federal contracts covering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This award for COSENTYX, an immunosuppressant medication used in treating inflammatory conditions, reflects AmerisourceBergen's continued role as a primary vendor for delivering essential pharmaceuticals to support military and veteran healthcare operations. The contract was competitively awarded with no set-aside designation, demonstrating the company's capability to meet federal procurement requirements in open competition.
Quick answers
Who was awarded contract SPE2DR26F1FRK?
SPE2DR26F1FRK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F1FRK worth?
The government has obligated $24,080 on SPE2DR26F1FRK.
Is contract SPE2DR26F1FRK an order under another contract?
Yes. SPE2DR26F1FRK is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1FRK competed?
The extent of competition for SPE2DR26F1FRK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award